Ovid Therapeutics Inc. (OVID) Tops Q3 EPS by 1c

Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q3 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $170 thousand versus the consensus estimate of $105.5 thousand.

For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Increasing unusual call volume: INDA LODE XIFR FRSH JMKE SYK BRUN MUU NRG LEN VIAV PAR ALM
• Home Depot (HD) call put ratio 1 call to 1.8 puts with a focus on August 332.5 puts into quarter results